Whit Mayo
Stock Analyst at Wells Fargo
(4.10)
# 491
Out of 4,876 analysts
212
Total ratings
55.91%
Success rate
10.1%
Average return
Main Sectors:
Stocks Rated by Whit Mayo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| FITB Fifth Third Bancorp | Maintains: Overweight | $48 → $52 | $41.51 | +25.27% | 7 | Jun 10, 2025 | |
| MS Morgan Stanley | Maintains: Equal-Weight | $130 → $120 | $140.69 | -14.71% | 7 | Apr 14, 2025 | |
| AIRS AirSculpt Technologies | Maintains: Market Perform | $6.5 → $2.5 | $4.90 | -48.98% | 5 | Mar 31, 2025 | |
| RF Regions Financial | Maintains: Equal-Weight | $28 → $26 | $23.35 | +11.35% | 6 | Mar 28, 2025 | |
| PNC The PNC Financial Services Group | Maintains: Overweight | $235 → $230 | $185.75 | +23.82% | 6 | Mar 28, 2025 | |
| BK The Bank of New York Mellon Corporation | Maintains: Equal-Weight | $86 → $96 | $91.18 | +5.29% | 7 | Mar 3, 2025 | |
| AHCO AdaptHealth | Maintains: Buy | $12 → $11 | $9.55 | +15.18% | 11 | Feb 13, 2025 | |
| EHAB Enhabit | Reiterates: Market Perform | $8.5 → $8 | $9.56 | -16.32% | 2 | Nov 19, 2024 | |
| BAC Bank of America | Maintains: Overweight | $52 → $56 | $47.12 | +18.85% | 5 | Nov 15, 2024 | |
| ARDT Ardent Health | Maintains: Outperform | $23 → $25 | $13.68 | +82.75% | 2 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $400 → $250 | $241.88 | +3.36% | 12 | Oct 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $100 | $122.20 | -18.17% | 1 | Jul 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $15 | $23.54 | -36.28% | 1 | Feb 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $45 → $52 | $59.46 | -12.55% | 2 | Dec 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $60 → $55 | $84.38 | -34.82% | 3 | Aug 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $625 → $560 | $309.11 | +81.17% | 11 | Jun 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $178.08 | - | 11 | May 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $50 → $38 | $51.47 | -26.17% | 1 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $420 → $390 | $690.81 | -43.54% | 1 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $98 → $97 | $106.00 | -8.49% | 1 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $165 → $155 | $193.78 | -20.01% | 1 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $21 → $20 | $17.22 | +16.14% | 1 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $309 → $335 | $326.31 | +2.66% | 5 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $580 | $381.49 | +52.04% | 3 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $96 → $85 | $97.92 | -13.19% | 16 | Jan 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $238 → $286 | $379.30 | -24.60% | 17 | Dec 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $55 → $40 | $21.95 | +82.23% | 7 | Nov 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $46 → $39 | $22.00 | +77.27% | 7 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $3 → $1.5 | $2.76 | -45.65% | 4 | Nov 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $33 → $30 | $2.31 | +1,198.70% | 5 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $20 → $16 | $14.03 | +14.04% | 10 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $89 → $55 | $173.63 | -68.32% | 14 | Oct 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $95 → $103 | $21.90 | +370.32% | 10 | Aug 26, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $235 → $175 | $98.43 | +77.79% | 1 | Apr 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $19 | $13.85 | +37.18% | 1 | Apr 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $5 → $4 | $3.39 | +17.99% | 6 | Jul 30, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Outperform | $183 → $203 | $260.59 | -22.10% | 2 | May 1, 2018 |
Fifth Third Bancorp
Jun 10, 2025
Maintains: Overweight
Price Target: $48 → $52
Current: $41.51
Upside: +25.27%
Morgan Stanley
Apr 14, 2025
Maintains: Equal-Weight
Price Target: $130 → $120
Current: $140.69
Upside: -14.71%
AirSculpt Technologies
Mar 31, 2025
Maintains: Market Perform
Price Target: $6.5 → $2.5
Current: $4.90
Upside: -48.98%
Regions Financial
Mar 28, 2025
Maintains: Equal-Weight
Price Target: $28 → $26
Current: $23.35
Upside: +11.35%
The PNC Financial Services Group
Mar 28, 2025
Maintains: Overweight
Price Target: $235 → $230
Current: $185.75
Upside: +23.82%
The Bank of New York Mellon Corporation
Mar 3, 2025
Maintains: Equal-Weight
Price Target: $86 → $96
Current: $91.18
Upside: +5.29%
AdaptHealth
Feb 13, 2025
Maintains: Buy
Price Target: $12 → $11
Current: $9.55
Upside: +15.18%
Enhabit
Nov 19, 2024
Reiterates: Market Perform
Price Target: $8.5 → $8
Current: $9.56
Upside: -16.32%
Bank of America
Nov 15, 2024
Maintains: Overweight
Price Target: $52 → $56
Current: $47.12
Upside: +18.85%
Ardent Health
Nov 12, 2024
Maintains: Outperform
Price Target: $23 → $25
Current: $13.68
Upside: +82.75%
Oct 2, 2024
Downgrades: Market Perform
Price Target: $400 → $250
Current: $241.88
Upside: +3.36%
Jul 10, 2024
Initiates: Outperform
Price Target: $100
Current: $122.20
Upside: -18.17%
Feb 20, 2024
Initiates: Outperform
Price Target: $15
Current: $23.54
Upside: -36.28%
Dec 14, 2023
Maintains: Underweight
Price Target: $45 → $52
Current: $59.46
Upside: -12.55%
Aug 23, 2023
Maintains: Overweight
Price Target: $60 → $55
Current: $84.38
Upside: -34.82%
Jun 14, 2023
Maintains: Outperform
Price Target: $625 → $560
Current: $309.11
Upside: +81.17%
May 26, 2023
Upgrades: Outperform
Price Target: n/a
Current: $178.08
Upside: -
Apr 3, 2023
Maintains: Equal-Weight
Price Target: $50 → $38
Current: $51.47
Upside: -26.17%
Apr 3, 2023
Maintains: Overweight
Price Target: $420 → $390
Current: $690.81
Upside: -43.54%
Apr 3, 2023
Maintains: Overweight
Price Target: $98 → $97
Current: $106.00
Upside: -8.49%
Apr 3, 2023
Maintains: Equal-Weight
Price Target: $165 → $155
Current: $193.78
Upside: -20.01%
Apr 3, 2023
Maintains: Overweight
Price Target: $21 → $20
Current: $17.22
Upside: +16.14%
Feb 8, 2023
Maintains: Market Perform
Price Target: $309 → $335
Current: $326.31
Upside: +2.66%
Jan 26, 2023
Reiterates: Outperform
Price Target: $580
Current: $381.49
Upside: +52.04%
Jan 5, 2023
Maintains: Market Perform
Price Target: $96 → $85
Current: $97.92
Upside: -13.19%
Dec 16, 2022
Maintains: Outperform
Price Target: $238 → $286
Current: $379.30
Upside: -24.60%
Nov 22, 2022
Maintains: Outperform
Price Target: $55 → $40
Current: $21.95
Upside: +82.23%
Nov 11, 2022
Maintains: Outperform
Price Target: $46 → $39
Current: $22.00
Upside: +77.27%
Nov 8, 2022
Maintains: Market Perform
Price Target: $3 → $1.5
Current: $2.76
Upside: -45.65%
Nov 4, 2022
Maintains: Outperform
Price Target: $33 → $30
Current: $2.31
Upside: +1,198.70%
Nov 4, 2022
Maintains: Market Perform
Price Target: $20 → $16
Current: $14.03
Upside: +14.04%
Oct 25, 2022
Maintains: Outperform
Price Target: $89 → $55
Current: $173.63
Upside: -68.32%
Aug 26, 2022
Maintains: Outperform
Price Target: $95 → $103
Current: $21.90
Upside: +370.32%
Apr 4, 2022
Maintains: Overweight
Price Target: $235 → $175
Current: $98.43
Upside: +77.79%
Apr 4, 2022
Initiates: Outperform
Price Target: $19
Current: $13.85
Upside: +37.18%
Jul 30, 2018
Maintains: Neutral
Price Target: $5 → $4
Current: $3.39
Upside: +17.99%
May 1, 2018
Assumes: Outperform
Price Target: $183 → $203
Current: $260.59
Upside: -22.10%